Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,826 | 539 | 99.3% |
| Education | $73.56 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,727 | 100 | $0 (2024) |
| Novo Nordisk Inc | $1,177 | 66 | $0 (2024) |
| ABBVIE INC. | $982.22 | 58 | $0 (2024) |
| Lilly USA, LLC | $746.13 | 41 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $719.75 | 39 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $681.86 | 31 | $0 (2022) |
| PFIZER INC. | $550.24 | 29 | $0 (2024) |
| Merck Sharp & Dohme LLC | $292.54 | 17 | $0 (2024) |
| Allergan, Inc. | $289.67 | 19 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $284.31 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,382 | 66 | ABBVIE INC. ($301.86) |
| 2023 | $1,144 | 59 | ABBVIE INC. ($362.25) |
| 2022 | $954.49 | 52 | ABBVIE INC. ($174.59) |
| 2021 | $1,124 | 63 | SANOFI-AVENTIS U.S. LLC ($153.46) |
| 2020 | $946.09 | 56 | AstraZeneca Pharmaceuticals LP ($182.89) |
| 2019 | $1,227 | 72 | AstraZeneca Pharmaceuticals LP ($335.63) |
| 2018 | $1,751 | 98 | AstraZeneca Pharmaceuticals LP ($525.25) |
| 2017 | $1,371 | 79 | AstraZeneca Pharmaceuticals LP ($273.28) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.19 | General |
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Obesity | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.75 | General |
| 09/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,055 | 1,776 | $481,999 | $155,385 |
| 2022 | 14 | 1,015 | 1,766 | $484,638 | $159,694 |
| 2021 | 14 | 1,115 | 1,952 | $488,633 | $171,307 |
| 2020 | 15 | 1,334 | 2,130 | $514,063 | $157,385 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 927 | $319,815 | $86,192 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 220 | 220 | $52,800 | $31,649 | 59.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 31 | 34 | $18,285 | $7,912 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 125 | $31,875 | $6,851 | 21.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 67 | 67 | $8,375 | $4,819 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 103 | 103 | $6,283 | $3,486 | 55.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 58 | 58 | $8,770 | $2,562 | 29.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $4,453 | $2,376 | 53.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,640 | $2,016 | 76.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 36 | 41 | $6,806 | $1,832 | 26.9% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 14 | 14 | $3,500 | $1,576 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $5,044 | $1,468 | 29.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 36 | 36 | $1,800 | $788.40 | 43.8% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 21 | $2,016 | $600.48 | 29.8% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 13 | 13 | $3,250 | $497.51 | 15.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 11 | 11 | $2,200 | $394.13 | 17.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $1,632 | $208.32 | 12.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 37 | $925.00 | $81.40 | 8.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 16 | 17 | $1,530 | $75.31 | 4.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 972 | $334,120 | $88,828 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 231 | 231 | $55,440 | $34,128 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 137 | $34,695 | $8,096 | 23.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 33 | $13,680 | $7,376 | 53.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 76 | 76 | $9,500 | $5,209 | 54.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 109 | 109 | $6,649 | $3,671 | 55.2% |
About Dr. Shunian He, MD
Dr. Shunian He, MD is a Internal Medicine healthcare provider based in Marlborough, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740207471.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shunian He, MD has received a total of $9,899 in payments from pharmaceutical and medical device companies, with $1,382 received in 2024. These payments were reported across 545 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,826).
As a Medicare-enrolled provider, He has provided services to 4,519 Medicare beneficiaries, totaling 7,624 services with total Medicare billing of $643,771. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Marlborough, MA
- Active Since 07/17/2006
- Last Updated 03/30/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1740207471
Products in Payments
- FARXIGA (Drug) $974.99
- Ozempic (Drug) $516.78
- XARELTO (Drug) $430.94
- ELIQUIS (Drug) $411.33
- VRAYLAR (Drug) $396.16
- SYMBICORT (Drug) $379.55
- JARDIANCE (Drug) $377.50
- SOLIQUA (Drug) $275.05
- SOLIQUA 100/33 (Biological) $267.17
- Victoza (Drug) $259.96
- INVOKANA (Drug) $244.90
- JANUVIA (Drug) $244.17
- UBRELVY (Drug) $243.23
- TRULICITY (Drug) $215.55
- Kerendia (Drug) $207.47
- LINZESS (Drug) $186.13
- Amitiza (Drug) $179.69
- Vascepa (Drug) $161.31
- ENTRESTO (Drug) $147.78
- MOUNJARO (Drug) $138.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marlborough
Marguerite Brackley, M.d, M.D
Internal Medicine — Payments: $291,890
Kathleen White, D.o, D.O
Internal Medicine — Payments: $3,625
Sangeetha Punjabi, Md, MD
Internal Medicine — Payments: $2,062
Lalita Matta, M.d, M.D
Internal Medicine — Payments: $986.61
Dolly Geevarghese, Md, MD
Internal Medicine — Payments: $743.99
Jose Flores Cardillo, Md, MD
Internal Medicine — Payments: $530.66